Towards Healthcare
Synovial Sarcoma Treatment Market to Capture $1214 Bn by 2034

Synovial Sarcoma Treatment Market Size & Exploring Novel Therapeutics

Forecasts suggest that the synovial sarcoma treatment market will expand from USD 852.36 million in 2024 to USD 1214 million by 2034, with a CAGR of 3.6% during this period. In 2023, surgery remained the leading treatment, holding a dominant 56% market share. North America led the market, accounting for 41% of the total share.

Last Updated : 01 November 2025 Category: Medical Devices Insight Code: 5121 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Synovial Sarcoma Treatment Market Assessment

  • Overview
  • Global Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Surgery
    • Radiation Therapy
    • Chemotherapy
    • Targeted Therapy
  • Global Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Specialty Clinics
    • Oncology Centers
    • Others
  • Global Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Synovial Sarcoma Treatment Market Assessment

  • Overview
  • North America Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Surgery
    • Radiation Therapy
    • Chemotherapy
    • Targeted Therapy
  • North America Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Specialty Clinics
    • Oncology Centers
    • Others

Europe Synovial Sarcoma Treatment Market Assessment

  • Overview
  • Europe Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Surgery
    • Radiation Therapy
    • Chemotherapy
    • Targeted Therapy
  • Europe Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Specialty Clinics
    • Oncology Centers
    • Others

Asia Pacific Synovial Sarcoma Treatment Market Assessment

  • Overview
  • Asia Pacific Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Surgery
    • Radiation Therapy
    • Chemotherapy
    • Targeted Therapy
  • Asia Pacific Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Specialty Clinics
    • Oncology Centers
    • Others

Middle East and Africa Synovial Sarcoma Treatment Market Assessment

  • Overview
  • Middle East and Africa Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Surgery
    • Radiation Therapy
    • Chemotherapy
    • Targeted Therapy
  • Middle East and Africa Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Specialty Clinics
    • Oncology Centers
    • Others

South America Synovial Sarcoma Treatment Market Assessment

  • Overview
  • South America Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by Treatment Type (2021 – 2033)
    • Surgery
    • Radiation Therapy
    • Chemotherapy
    • Targeted Therapy
  • South America Synovial Sarcoma Treatment Market Size Value (US$) and Volume (Million Tons), by End User (2021 – 2033)
    • Hospitals
    • Specialty Clinics
    • Oncology Centers
    • Others

Company Profiles

  • Novartis
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Eli Lilly and Company
  • Adaptimmune
  • Takara Bio Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Eisai Co., Ltd.
  • Aadi Biosciences
  • Immunocore Ltd.
  • GlaxoSmithKline

Conclusion & Recommendations

FAQ's

Answer : Synovial sarcoma is a type of cancer that typically affects soft tissues near joints, most commonly in the arms or legs. It is characterized by its tendency to occur in adolescents and young adults and is known for its specific genetic abnormalities.

Answer : The market for synovial sarcoma treatment is primarily dominated by chemotherapy.

Answer : Hurdles occur due to limited awareness.

Answer : National Institute of Health, American Cancer Society, World Health Organization, Center for Disease Control and Prevention, ScienceDirect Publication.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar